Antibiotic use, certain gut bacteria affect CAR-T efficacy, toxicity

The use of broad-spectrum antibiotics in the month leading up to chimeric antigen receptor T-cell therapy led to poorer outcomes and increased treatment-related toxicities, study results showed.Certain types of gut bacteria had an impact on treatment efficacy and related toxicities among patients who received CAR-T for non-Hodgkin lymphoma or acute lymphoblastic leukemia, researchers reported.CAR T-cell therapies have produced “significant benefit for patients” in terms of overall response rates and survival, according to Melody Smith, MD, assistant professor of medicine in theRead More

Generated by Feedzy